Team17 Group (LON:TM17) Stock Price Up 1.3%

Team17 Group plc (LON:TM17Get Rating) traded up 1.3% during mid-day trading on Friday . The company traded as high as GBX 385 ($4.82) and last traded at GBX 380 ($4.76). 19,656 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 398,797 shares. The stock had previously closed at GBX 375 ($4.70).

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Shore Capital reissued a “buy” rating on shares of Team17 Group in a research note on Friday, April 28th. Berenberg Bank reissued a “buy” rating and issued a GBX 650 ($8.14) price objective on shares of Team17 Group in a research note on Tuesday, April 11th.

Team17 Group Trading Up 1.3 %

The stock’s 50 day moving average price is GBX 384.01 and its 200-day moving average price is GBX 425.77. The company has a quick ratio of 2.28, a current ratio of 1.63 and a debt-to-equity ratio of 1.18. The stock has a market capitalization of £554.04 million, a PE ratio of 2,375.00, a PEG ratio of 3.16 and a beta of 0.80.

Insider Transactions at Team17 Group

In related news, insider Mark Crawford purchased 6,622 shares of Team17 Group stock in a transaction on Friday, March 31st. The shares were bought at an average cost of GBX 378 ($4.74) per share, for a total transaction of £25,031.16 ($31,355.58). Corporate insiders own 27.42% of the company’s stock.

About Team17 Group

(Get Rating)

Team17 Group plc, together with its subsidiaries, develops video games for independent developers worldwide. The company develops and publishes owned and third-party IP video games for the digital and physical market. Its games portfolio comprises approximately 100 games, including the Worms franchise, Overcooked!, and The Escapists.

Recommended Stories

Receive News & Ratings for Team17 Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Team17 Group and related companies with MarketBeat.com's FREE daily email newsletter.